Cargando…

Disease monitoring of hepatocellular carcinoma through metabolomics

We elucidate major pathways of hepatocarcinogenesis and accurate diagnostic metabolomic biomarkers of hepatocellular carcinoma (HCC) identified by contemporary HCC metabolomics studies, and delineate a model HCC metabolomics study design. A literature search was carried out on Pubmed for HCC metabol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitian, Asem I, Cabrera, Roniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220267/ https://www.ncbi.nlm.nih.gov/pubmed/28105254 http://dx.doi.org/10.4254/wjh.v9.i1.1

Ejemplares similares

Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies
por: Sun, Weijing, et al.
Publicado: (2018)

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
por: Dhanasekaran, Renumathy, et al.
Publicado: (2012)

Intractable Fasting Hypoglycemia as a Manifestation of Hepatocellular Carcinoma
por: Forde, Justin J., et al.
Publicado: (2017)

Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation
por: Ismael, Media N., et al.
Publicado: (2019)

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
por: Guo, Wei, et al.
Publicado: (2018)

Infectious Diseases of Children
por: Musmar, Samar, et al.
Publicado: (2016)

Advances in the management of cholangiocarcinoma
por: Zori, Andreas G, et al.
Publicado: (2021)

A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis
por: Zhang, Wei, et al.
Publicado: (2021)

Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
por: King, William W, et al.
Publicado: (2023)

Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
por: Ozer, Muhammet, et al.
Publicado: (2023)

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring
por: Hennedige, Tiffany, et al.
Publicado: (2013)

Salivary Metabolomics for Diagnosis and Monitoring Diseases: Challenges and Possibilities
por: Hyvärinen, Eelis, et al.
Publicado: (2021)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Metabolomic biomarkers for hepatocellular carcinoma: A systematic review
por: Feng, Ningning, et al.
Publicado: (2022)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
por: Cabrera, Roniel, et al.
Publicado: (2020)

Rare Case of Adult Undifferentiated (Embryonal) Sarcoma of the Liver Treated with Liver Transplantation: Excellent Long-Term Survival
por: Dhanasekaran, Renumathy, et al.
Publicado: (2012)

Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
por: Wang, Li, et al.
Publicado: (2013)

The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
por: Kopystecka, Agnieszka, et al.
Publicado: (2023)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma
por: Choi, Eun-Ji, et al.
Publicado: (2022)

Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases
por: Chen, Zhaohui, et al.
Publicado: (2016)

Prevention of hepatocellular carcinoma and monitoring of high-risk patients
por: Kaya, Eda, et al.
Publicado: (2022)

Real-time health monitoring through urine metabolomics
por: Miller, Ian J., et al.
Publicado: (2019)

Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
por: Gao, Rong, et al.
Publicado: (2015)

Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
por: Fages, Anne, et al.
Publicado: (2015)

Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature
por: Tambay, Vincent, et al.
Publicado: (2023)

Metabolomic analysis of vascular cognitive impairment due to hepatocellular carcinoma
por: Zhu, Dan, et al.
Publicado: (2023)

Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
por: Wu, Xingyun, et al.
Publicado: (2023)

Salivary Metabolomics in the Diagnosis and Monitoring of Neurodegenerative Dementia
por: Hyvärinen, Eelis, et al.
Publicado: (2023)

Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma
por: Faccia, Mariella, et al.
Publicado: (2022)

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights
por: Cammarota, Antonella, et al.
Publicado: (2022)

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma
por: Liu, Jinkai, et al.
Publicado: (2022)

Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma
por: Sanabria, Juan R., et al.
Publicado: (2016)

The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells
por: Qin, Xian-Yang, et al.
Publicado: (2013)

Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study
por: Chen, Yang, et al.
Publicado: (2016)

Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Murakami, Yoshiki, et al.
Publicado: (2015)

Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma
por: Zhou, Peng-Cheng, et al.
Publicado: (2020)

The Immunology of Hepatocellular Carcinoma
por: Lawal, Gbemisola, et al.
Publicado: (2021)

Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA
por: Wu, Cheng-Heng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q7118157f5rijuthn8b3v4u247